Clinical Research
Clinical research is led by Dr. Varun Chaudhary and his research team.
Dr. Varun Chaudhary leads clinical research focused on neovascular (wet) age-related macular degeneration, diabetic macular edema, retinal vein occlusion, individualized treatment paradigms, imaging biomarker analysis.
He serves as Principal Investigator for studies including INSITE-DME and the R.E.A.D. study, focused on diabetic macular edema and age-related macular degeneration. He is also a member of multiple global scientific steering committees for Phase III and Phase IV clinical trials in macular diseases.
The research team participates in national and international studies evaluating treatment strategies and patient outcomes in age-related macular degeneration, diabetic macular edema and retinal vein occlusion.
Clinical research activities are conducted in accordance with institutional and regulatory requirements and are separate from clinical care services.
Structured Research Studies
What Are Clinical Trials?
Clinical trials are structured research studies that evaluate new treatments, medications, and diagnostic approaches.
These studies are conducted under strict regulatory and ethical oversight to ensure patient safety, data integrity, and clinical validity.
Participation in clinical trials is voluntary and may be considered for eligible patients. Clinical trials contribute to advancing knowledge and improving the care of retinal diseases.
Participation in clinical trials is subject to eligibility and informed consent.
Our Expertise
Areas of Research
Clinical research activities focus on the following areas:
- Neovascular (Wet) Age-Related Macular Degeneration (nAMD)
- Diabetic Macular Edema (DME)
- Retinal Vein Occlusion (RVO)
Research studies may evaluate:
- New therapeutic agents
- Extended-duration treatment options
- Alternative delivery methods
- Advanced imaging and monitoring strategies
HOW PATIENTS ARE CONSIDERED
Patient Eligibility and Participation
Patients may be considered for clinical trial participation based on their diagnosis, clinical history, and study-specific criteria. Participation is voluntary.
Before enrollment:
- Patients undergo a detailed screening process
- Study requirements are explained clearly
- Informed consent is obtained
Not all patients will qualify for every study. Participation in a clinical trial does not affect access to standard clinical care. Participation may be withdrawn at any time.